Endo Wins Chapter 11 Plan Approval to Cut Debt, Resolve Opioid Lawsuits
Wall Street Journal
Drugmaker Endo International said it won court approval for its bankruptcy plan to eliminate $5.5 billion in debt and resolve thousands of lawsuits related to its opioids and other products.